Related Experiment Video

Updated: Sep 20, 2026

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
07:54

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

Published on: August 29, 2018

Proteomics of heart disease

Emma McGregor1, Michael J Dunn

  • 1Proteome Sciences plc, Kings College, University of London, London SE5 8AF, UK. m.dunn@iop.kcl.ac.uk

Human Molecular Genetics
|August 21, 2003
PubMed

Insights

Proteomics enables the study of protein changes in heart failure, offering insights into cardiac dysfunction and potential new diagnostic and therapeutic markers for heart disease.

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Molecular Biology

Background:

  • Heart failure is a major cause of death globally.
  • The molecular basis of heart failure remains poorly understood.
  • Altered gene and protein expression likely contribute to cardiac dysfunction.

Purpose of the Study:

  • To review the current status of proteomic technologies.
  • To describe the application of proteomics in human heart disease research.
  • To highlight the potential of proteomics for discovering new diagnostic and therapeutic markers.

Main Methods:

  • Global analysis of protein expression in diseased heart tissue.
  • Application of advanced proteomic techniques.
  • Review of existing literature on proteomics in heart disease.

Main Results:

  • Proteomics allows examination of global protein expression alterations in heart disease.
  • Proteomic studies provide insights into cellular mechanisms of cardiac dysfunction.
  • Proteomics holds promise for identifying novel biomarkers.

Conclusions:

  • Proteomics is a powerful tool for understanding heart disease.
  • Further application of proteomic technologies is crucial for advancing cardiovascular research.
  • Proteomics can lead to improved diagnostics and therapeutics for heart failure.

More Related Videos

Quantitative Analysis of Chromatin Proteomes in Disease08:11

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...